MacroGenics, Inc. - Common Stock (NQ:MGNX)

2.390 +0.010 (+0.42%)

Delayed Quote Updated: 2:13 PM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MacroGenics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Why Is Progyny (PGNY) Stock Down 27% Today? ↗

May 10, 2024

Progyny stock is down on Friday after the company posted a revenue miss for Q1 and disappointed PGNY investors with its guidance!

Via InvestorPlace

Why Natera Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket ↗

May 10, 2024

Via Benzinga

Why Is Macrogenics (MGNX) Stock Down 69% Today? ↗

May 10, 2024

Macrogenics stock is down on Friday as MGNX investors react to clinical trial deaths and missed earnings for the first quarter of 2024.

Via InvestorPlace

Topics Death

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 10, 2024

Via Benzinga

The Latest Analyst Ratings For Macrogenics ↗

April 04, 2024

Via Benzinga

MacroGenics Inc. (NASDAQ: MGNX) Leading the Way in Thursday Trading Based on Percentage Gain

April 04, 2024

Via Investor Brand Network

Macrogenics: Q4 Earnings Insights ↗

March 07, 2024

Via Benzinga

A Preview Of Macrogenics's Earnings ↗

March 06, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

May 10, 2024

The biggest pre-market stock movers are ready to go as we check out all of the hottest news happening on Friday morning!

Via InvestorPlace

Akamai Technologies Issues Weak Outlook, Joins Applied Optoelectronics, JFrog And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

May 10, 2024

Via Benzinga

MacroGenics (MGNX) Q1 2024 Earnings Call Transcript ↗

May 10, 2024

MGNX earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

MGNX Stock Earnings: Macrogenics Misses EPS, Misses Revenue for Q1 2024 ↗

May 09, 2024

MGNX stock results show that Macrogenics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 3/5

March 05, 2024

Via Investor Brand Network

Analyst Expectations For Macrogenics's Future ↗

March 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 09, 2024

Via Benzinga

MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call

May 03, 2024

From MacroGenics, Inc.

Via GlobeNewswire

Masters In Trading - Saturday, April 27 ↗

April 27, 2024

In this recap of the most recent trading session, I review my portfolio and share one of the trades taken this week.

Via Talk Markets

Look Out For These 6 Stocks As Analysts Predicts Major Gains, One Up To 82% ↗

April 05, 2024

Investment analysts have revised their price targets upwards for six major stocks this week, with one company expected to see an 82% surge. The revised targets include four U.S.-listed companies, with...

Via Benzinga

MacroGenics Analyst Impressed By Improved Safety Profile From Prostate Cancer Candidate ↗

April 04, 2024

Update on MacroGenics Inc's Phase 2 TAMARACK study of vobramitamab duocarmazine (vobra duo) for metastatic castration-resistant prostate cancer (mCRPC). Safety and preliminary efficacy data anticipated...

Via Benzinga

Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 04, 2024

Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3%...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 04, 2024

Via Benzinga

Simulations Plus Posts Upbeat, Joins Levi Strauss, BlackBerry And Other Big Stocks Moving Higher In Thursday's Pre-Market Session ↗

April 04, 2024

U.S. stock futures were higher this morning, with the Dow futures gaining by around 90 points on Thursday.

Via Benzinga

Topics Stocks

MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures

April 03, 2024

From MacroGenics, Inc.

Via GlobeNewswire

MacroGenics (MGNX) Q4 2023 Earnings Call Transcript ↗

March 08, 2024

MGNX earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

MGNX Stock Earnings: Macrogenics Misses EPS for Q4 2023 ↗

March 07, 2024

MGNX stock results show that Macrogenics missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 07, 2024

Via Benzinga

AMD To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday ↗

March 04, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

MacroGenics to Participate in Upcoming Investor Conferences

March 01, 2024

From MacroGenics, Inc.

Via GlobeNewswire

MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call

February 27, 2024

From MacroGenics, Inc.

Via GlobeNewswire

Earnings Scheduled For March 7, 2024 ↗

March 07, 2024

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.